DJIA 18,187.38 -27.04 -0.15%
NASDAQ 4,978.49 -9.40 -0.19%
S&P 500 2,110.90 0.16 0.01%
market minute promo

Hospira, Inc. (NYSE: HSP)



company name or ticker
Company Photos
(Click to zoom)

Volatility Index signals that the bull has room to run

Pfizer Rapamune Under FDA Priority Review for Lung Disease - Analyst Blog

Valeant Pharmaceuticals Buys Salix Pharmaceuticals in $14.5 Billion Megadeal

Pssst... Pfizer Just Told Investors That This is the Next Big Thing

Pfizer Inc.'s acquisition of Hospira could signal that investors should embrace biosimilar drugmakers.

$20 Billion Market: What’s the Best Stock to Buy?

Three drug companies to watch as biologics come off patent and investors anticipate a biosimilar boom -- here's what you need to know.

Hot Dividend Stocks: Pfizer Pulls Back Into Buy Range

The Medicines Co. Earnings Down Y/Y, Angiomax Sales Grow - Analyst Blog

Hospira's Q4 Earnings Were Bright, Though Acquisition Is In The Cards

Hospira Launches Inflectra, Remicade Biosimilar, in Europe - Analyst Blog

Hospira Launches Inflectra, Remicade Biosimilar, in Europe - Analyst Blog

Pfizer NDA on Pain Management Candidate Accepted by FDA - Analyst Blog

Pfizer NDA on Pain Management Candidate Accepted by FDA - Analyst Blog
See More Articles...